Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ou-Chen Wang
Observed names:
O. Wang,
O., Wang
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institution:
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0000-0002-1891-2142
Observed ORCID:
0000-0002-1891-2142
OpenAlex ID:
A5049077614
Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
2025
·
Yi-Zi Zheng
, Jia-Qi Ying
, et al.
·
The Breast
·
10
PDF
Evaluation of serum hepcidin concentrations in cancer and leukemia patients
2008
·
T. C. Arvedson
, H. Li
, et al.
·
Journal of Clinical Oncology
·
4
Abstract P5-12-15: Survival Nomogram Including Lymph Node Ratio for Patients with Invasive Micropapillary Breast Cancer
2025
·
Yi-Zi Zheng
, Yan Liu
, et al.
·
Clinical Cancer Research
Supplementary Material for: Neoadjuvant pyrotinib plus trastuzumab, docetaxel, and carboplatin in early or locally advanced HER2-positive breast cancer in China: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
2023
·
Y., Ding
, W., Mo
, et al.
·
Figshare
Validation of a sensitive and quantitative biomarker method for the determination of hepcidin in human serum
2008
·
M. J. Rose
, H. Li
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
5
Citation count:
14
H-index:
2
I10-index:
1
Year
Topic
Type